Fingerprint
Dive into the research topics of 'Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeks'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeks
Steven R. Alberts, Charles Erlichman, Joel M. Reid, Jeff A. Sloan, Matthew M. Ames, Ronald L. Richardson, Richard M. Goldberg
Research output: Contribution to journal › Article › peer-review
22
Scopus
citations